The M protein of group A streptococcus is a key virulence factor and a clinically relevant strain identification marker

Virulence

Volumn 2, Issue 5, 2011, Pages 402-412

  Metzgar, David ^a   Zampolli, Antonella ^b  

^a Ibis Biosciences (a Subsidiary of Abbott Inc)   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Acute rheumatic fever; ARF; Epidemic; Group A streptococcus; PSGN; Public health; RHD; Rheumatic heart disease; Streptococcal toxic shock syndrome

Indexed keywords

BACITRACIN; EPITOPE; ERYTHROMYCIN; EXOTOXIN; M PROTEIN; PENICILLIN G; TETRACYCLINE;

ACUTE GLOMERULONEPHRITIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; ENDOCARDITIS; FATALITY; FRAMESHIFT MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; GROUP A STREPTOCOCCAL INFECTION; IMPETIGO; MENINGITIS; MICROBIAL DIVERSITY; MOLECULAR EPIDEMIOLOGY; NECROTIZING FASCIITIS; NONHUMAN; OPEN READING FRAME; PERITONITIS; PHARYNGITIS; RHEUMATIC FEVER; RHINOPHARYNGITIS; SEPSIS; SEROTYPE; STRAIN IDENTIFICATION; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME; TROPISM; VARICELLA ZOSTER VIRUS;

STREPTOCOCCUS SP. 'GROUP A';

EID: 80053907181     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.5.16342     Document Type: Article

References (76)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511; PMID:10885988; http://dx.doi.org/10.1128/CMR.13.3.470-511.2000.
2. Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis 2001; 33:806-14; PMID:11512086; http://dx.doi.org/10.1086/322665.
3. Anthony BF, Kaplan EL, Wannamaker LW, Chapman SS. The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. Am J Epidemiol 1976; 104:652-666; PMID:793381.
4. Bessen DE. Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol 2009; 9:581-593; PMID:19460325; http://dx.doi.org/10.1016/j.meegid.2009.03.002.
5. McDonald M, Currie BJ, Carapetis JR. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 2004; 4:240-245; PMID:15050943; http://dx.doi.org/10.1016/S1473-3099(04)00975-2.
6. Oehmcke S, Shannon O, Mörgelin M, Herwald H. Streptococcal M proteins and their role as virulence determinants. Clin Chim Acta 2010; 411:1172-1180; PMID:20452338; http://dx.doi.org/10.1016/j.cca.2010.04.032.
7. Smeesters PR, McMillan DJ, Sriprakash KS. The streptococcal M protein: a highly versatile molecule. Trends Microbiol 2010; 18:275-282; PMID:20347595; http://dx.doi.org/10.1016/j.tim.2010.02.007.
8. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167-1171; PMID:1978035; http://dx.doi.org/10.1016/0140-6736(90)92777-F.
9. Bessen D, Jones KF, Fischetti VA. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 1989; 169:269-283; PMID:2642529; http://dx.doi.org/10.1084/jem.169.1.269.
10. Stollerman GH. Rheumatic fever. Lancet 1997; 349:935-942; PMID:9093263; http://dx.doi.org/10.1016/S0140-6736(96)06364-7.
11. Bisno AL. The concept of rheumatogenic and nonrheumatogenic group A streptococci. In: Read SE, Zabriskie JB, Eds. Streptococcal Diseases and the Immune Response. New York, NY: Academic Press Inc. 1980; 789-903.
12. Banks DJ, Beres SB, Musser JM. The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol 2002; 10:515-521; PMID:12419616; http://dx.doi.org/10.1016/S0966-842X(02)02461-7.
13. Kehoe MA, Kapur V, Whatmore AM, Musser JM. Horizontal gene transfer among group A streptococci: implications for pathogenesis and epidemiology. Trends Microbiol 1996; 4:436-443; PMID:8950813; http://dx.doi.org/10.1016/0966-842X(96)10058-5.
14. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 2005; 192:771-782; PMID:16088826; http://dx.doi.org/10.1086/432514.
15. Lancefield RC. The antigenic complex of Streptococcus hemolyticus. I. Demonstration of a type-specific substance in extracts of Streptococcus hemolyticus. J Exp Med 1928; 47:91-103; PMID:19869404; http://dx.doi.org/10.1084/jem.47.1.91.
16. Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 1989; 2:285-314; PMID:2670192.
17. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, et al. emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis 1999; 5:247-253; PMID:10221877; http://dx.doi. org/10.3201/eid0502.990209.
18. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325:783-793; PMID:1870652; http://dx.doi.org/10.1056/NEJM199109123251106.
19. Robinson JH, Kehoe MA. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today 1992; 13:362-367; PMID:1281632; http://dx.doi.org/10.1016/0167-5699(92)90173-5.
20. Musser JM, Shelburne SA, 3rd. A decade of molecular pathogenomic analysis of group A Streptococcus. J Clin Invest 2009; 119:2455-2463; PMID:19729843; http://dx.doi.org/10.1172/JCI38095.
21. Metzgar D, McDonough EM, Hansen CJ, Blaesing CR, Baynes D, Hawksworth AW, et al. Local changes in rates of group A Streptococcus disease and antibiotic resistance are associated with geographically widespread strain turnover events. Virulence 2010; 1:247-253; PMID:21178449; http://dx.doi.org/10.4161/viru.1.4.11979.
22. Siljander T, Lyytikäinen O, Vähäkuopus S, Snellman M, Jalava J, Vuopio J. Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland. Eur J Clin Microbiol Infect Dis 2010; 29:1229-1235; PMID:20563620; http://dx.doi.org/10.1007/s10096-010-0989-9.
23. Johnson DR, Wotton JT, Shet A, Kaplan EL. A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections? J Infect Dis 2002; 185:1586-1595; PMID:12023764; http://dx.doi.org/10.1086/340576.
24. Kaplan EL, Wotton JT, Johnson DR. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet 2001; 358:1334-1337; PMID:11684215; http://dx.doi.org/10.1016/S0140-6736(01)06415-7.
25. Sun H, Ringdhal U, Homeister JW, Fay WP, Engleberg NC, Yang AY, et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004; 305:1283-1286; PMID:15333838;http://dx.doi.org/10.1126/science.1101245.
26. Påhlman LI, Malmström E, Mörgelin M, Herwald H. M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes. Microbiology 2007; 153:2458-2464; PMID:17660410; http://dx.doi.org/10.1099/mic.0.2006/003285-0.
27. Sjöbring U, Ringdahl U, Ruggeri ZM. Induction of platelet thrombi by bacteria and antibodies. Blood 2002; 100:4470-4477; PMID:12393652; http://dx.doi.org/10.1182/blood-2002-01-0069.
28. Shannon O, Hertzén E, Norrby-Teglund A, Mörgelin M, Sjöbring U, Björck L. Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol 2007; 65:1147-1157; PMID:17662041; http://dx.doi. org/10.1111/j.1365-2958.2007.05841.x
29. Påhlman LI, Mörgelin M, Eckert J, Johansson L, Russell W, Riesbeck K, et al. Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 2006; 177:1221-1228; PMID:16818781.
30. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009; 9:611-616; PMID:19778763; http://dx.doi.org/10.1016/S1473-3099(09)70178-1.
31. Wang B, Schlievert PM, Gaber AO, Kotb M. Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. J Immunol 1993; 151:1419-1429; PMID:8335938.
32. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States 2000-2004. Clin Infect Dis 2007; 45:853-862; PMID:17806049; http://dx.doi.org/10.1086/521264.
33. Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinhøj P, et al. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol 2005; 43:3101-3109; PMID:16000420; http://dx.doi.org/10.1128/JCM.43.7.3101-9.2005.
34. Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 2008; 46:79-86; PMID:17959766; http://dx.doi.org/10.1128/JCM.01626-07.
35. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993; 269:384-389; PMID:8418346; http://dx.doi.org/10.1001/jama.269.3.384.
36. Meisal R, Andreasson IK, Høiby EA, Aaberge IS, Michaelsen TE, Caugant DA. Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types and superantigen profiles. J Clin Microbiol 2010; 48:842-851; PMID:20042624; http://dx.doi.org/10.1128/JCM.01312-09.
37. Mihaila-Amrouche L, Bouvet A, Loubinoux J. Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. J Clin Microbiol 2004; 42:3844-3846; PMID:15297545; http://dx.doi.org/10.1128/JCM.42.8.3844-6.2004.
38. Szczypa K, Sadowy E, Izdebski R, Strakova L, Hryniewicz W. Group A streptococci from invasivedisease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol 2006; 44:3975-3979; PMID:16957033; http://dx.doi.org/10.1128/JCM.01163-06.
39. Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, Sylva GL, et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA 2002; 99:4668-4673; PMID:11917108; http://dx.doi.org/10.1073/pnas.062526099.
40. Shulman ST, Stollerman G, Beall B, Dale JB, Tanz RR. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis 2006; 42:441-447; PMID:16421785; http://dx.doi.org/10.1086/499812.
41. Kiska DL, Thiede B, Caracciolo J, Jordan M, Johnson D, Kaplan EL, et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features and genetic and serotype analysis of causative organisms. J Infect Dis 1997; 176:992-1000; PMID:9333158; http://dx.doi.org/10.1086/516540.
42. Wannamaker LW, Denny FW, Perry WD, Rammelkamp CH Jr, Eckhardt GC, Houser HB, et al. The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state. N Engl J Med 1953; 249:1-7; PMID:13063671; http://dx.doi.org/10.1056/NEJM195307022490101.
43. Russell KL. Respiratory infections in military recruits. In: Lenhart MK, Lounsbury DE, North RB Jr, Eds. Textbooks of Military Medicine: Recruit Medicine. Washington, DC: Borden Institute (Walter Reed Army Medical Center) 2006; 1:227-253.
44. Metzgar D, Baynes D, Hansen CJ, McDonough EA, Cabrera DR, Ellorin MM, et al. Inference of antibiotic resistance and virulence among diverse group A Streptococcus strains using emm sequencing and multilocus genotyping methods. PLoS ONE 2009; 4:6897; PMID:19730733; http://dx.doi.org/10.1371/journal.pone.0006897.
45. Horn DL, Zabriskie JB, Austrian R, Cleary PP, Ferretti JJ, Fischetti VA, et al. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 1998; 26:1341-1345; PMID:9636860; http://dx.doi.org/10.1086/516375.
46. Ayer V, Tewodros W, Manoharan A, Skariah S, Luo F, Bessen DE. Tetracycline resistance in group a streptococci: emergence on a global scale and influence on multiple-drug resistance. Antimicrob Agents Chemother 2007; 51:1865-1868; PMID:17307980; http://dx.doi.org/10.1128/AAC.01341-06.
47. Giovanetti E, Brenciani A, Lupidi R, Roberts MC, Varaldo PE. Presence of the tet(O) gene in erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene. Antimicrob Agents Chemother 2003; 47:2844-2849; PMID:12936983; http://dx.doi.org/10.1128/AAC.47.9.2844-9.2003.
48. Vitali LA, D'Ercole S, Petrelli D, Di Luca MC, Rombini S, Prenna M, et al. Distribution of phageassociated virulence genes in pharyngeal group a streptococcal strains isolated in Italy. J Clin Microbiol 2009; 47:1575-1577; PMID:19279174; http://dx.doi.org/10.1128/JCM.00925-08.
49. Kaplan EL, Johnson DR, Del Rosario MC, Horn DL. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr Infect Dis J 1999; 18:1069-1072; PMID:10608626;http://dx.doi.org/10.1097/00006454-199912000-00008.
50. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburg. N Engl J Med 2002; 346:1200-1206; PMID:11961148; http://dx.doi.org/10.1056/NEJMoa013169.
51. Descheemaeker P, Chapelle S, Lammens C, Hauchecorne M, Wijdooghe M, Vandamme P, et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother 2000; 45:167-173; PMID:10660498; http://dx.doi.org/10.1093/jac/45.2.167.
52. Grivea IN, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob Agents Chemother 2006; 50:256-261; PMID:16377695; http://dx.doi.org/10.1128/AAC.50.1.256-61.2006.
53. Albertí S, García-Rey C, Domínguez MA, Aguilar L, Cercenado E, Gobernado M, et al. Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility. J Clin Microbiol 2003; 41:2385-2390; PMID:12791853; http://dx.doi.org/10.1128/JCM.41.6.2385-90.2003.
54. Perez-Trallero E, Marimo'n JM, Montes M, Orden B, de Pablos M. Clonal differences among erythromycinresistant Streptococcus pyogenes in Spain. Emerg Infect Dis 1999; 5:235-240; PMID:10221875; http://dx.doi.org/10.3201/eid0502.990207.
55. Creti R, Gherardi G, Imperi M, von Hunolstein C, Baldassarri L, Pataracchia M, et al. Association of group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation. J Med Microbiol 2005; 54:913-917; PMID:16157543; http://dx.doi.org/10.1099/jmm.0.46035-0.
56. Palmieri C, Vecchi M, Littauer P, Sundsfjord A, Varaldo PE, Facinelli B. Clonal spread of macrolide- and tetracycline-resistant [erm(A) tet(O)] emm77 Streptococcus pyogenes isolates in Italy and Norway. Antimicrob Agents Chemother 2006; 50:4229-4230; PMID:17043129; http://dx.doi.org/10.1128/AAC.00943-06.
57. Nielsen HU, Hammerum AM, Ekelund K, Bang D, Pallesen LV, Frimodt-Møller N. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: coselection as a reason for increase in macrolide-resistant S. pyogenes? Microb Drug Resist 2004; 10:231-238; PMID:15383167.
58. McGregor KF, Bilek N, Bennett A, Kalia A, Beall B, Carapetis JR, et al. Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J Infect Dis 2004; 189:717-723; PMID:14767827; http://dx.doi.org/10.1086/381452.
59. Pruksakorn S, Sittisombut N, Phornphutkul C, Pruksachatkunakorn C, Good MF, Brandt E. Epidemiological analysis of non-M-typeable group A Streptococcus isolates from a Thai population in northern Thailand. J Clin Microbiol 2000; 38:1250-1254; PMID:10699034.
60. Kaplan EL, Johnson DR, Nanthapisud P, Sirilertpanrana S, Chumdermpadetsuk S. A comparison of group A streptococcal serotypes isolated from the upper respiratory tract in the USA and Thailand: implications. Bull World Health Organ 1992; 70:433-437; PMID:1394774.
61. Tewodros W, Kronvall G. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. J Clin Microbiol 2005; 43:4369-4376; PMID:16145079; http://dx.doi.org/10.1128/JCM.43.9.4369-76.2005.
62. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever or uncomplicated pharyngitis. J Infect Dis 1992; 166:374-382; PMID:1634809; http://dx.doi.org/10.1093/infdis/166.2.374.
63. Tamayo E, Montes M, García-Medina G, García-Arenzana JM, Pérez-Trallero E. Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone. BMC Infect Dis 2010; 10:233; PMID:20687911; http://dx.doi.org/10.1186/1471-2334-10-233.
64. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7; PMID:2659990; http://dx.doi.org/10.1056/NEJM198907063210101.
65. Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339:518-521; PMID:1346879; http://dx.doi.org/10.1016/0140-6736(92)90339-5.
66. Gaworzewska ET, Hallas G. Group A streptococcal infections and a toxic shock-like syndrome. N Engl J Med 1989; 321:1545-1547; PMID:2682245; http://dx.doi.org/10.1056/NEJM198911303212212.
67. Holden MT, Scott A, Cherevach I, Chillingworth T, Churcher C, Cronin A, et al. Complete genome of acute rheumatic fever-associated serotype M5 Streptococcus pyogenes strain Manfredo. J Bacteriol 2007; 189:1473-1477; PMID:17012393; http://dx.doi.org/10.1128/JB.01227-06.
68. Beres SB, Sylva GL, Sturdevant DE, Granville CN, Liu M, Ricklefs SM, et al. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci USA 2004; 101:11833-11838; PMID:15282372;http://dx.doi.org/10.1073/pnas.0404163101.
69. Beres SB, Richter EW, Nagiec MJ, Sumby P, Porcella SF, DeLeo FR, et al. Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci USA 2006; 103:7059-7064; PMID:16636287; http://dx.doi.org/10.1073/pnas.0510279103.
70. American Academy of Pediatrics. Committee on Infectious Diseases. Severe invasive group A streptococcal infections: a subject review. Pediatrics 1998; 101:136-140; PMID:11345977; http://dx.doi.org/10.1542/peds.101.1.136.
71. Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000; 105:60; PMID:10799624;http://dx.doi.org/10.1542/peds.105.5.e60.
72. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63:994-1003; PMID:7868273.
73. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2006; 2:5;PMID:16446783; http://dx.doi.org/10.1371/journal.ppat.0020005.
74. Barrozo CP, Russell KL, Smith TC, Hawksworth AW, Ryan MAK, Gray GC. National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites. J Clin Microbiol 2003; 41:4808-4811; PMID:14532227;http://dx.doi.org/10.1128/JCM.41.10.4808-11.2003.
75. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun 2001; 69:2416-2427; PMID:11254602; http://dx.doi.org/10.1128/IAI.69.4.2416-27.2001.
76. Reid SD, Hoe NP, Smoot LM, Musser JM, Group A. Streptococcus: allelic variation, population genetics and host-pathogen interactions. J Clin Invest 2001; 107:393-399; PMID:11181637; http://dx.doi.org/10.1172/JCI11972.